MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis

Journal of the Neurological Sciences

Volumn 263, Issue 1-2, 2007, Pages 191-193

  Yeh, Jiann Horng ^a,b   Chen, Wei Hung ^a,c   Chiu, Hou Chang ^a,b   Bai, Chyi Huey ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Clearance rate; Double filtration plasmapheresis; MuSK antibody; Plasma exchange; Seronegative myasthenia gravis

Indexed keywords

AZATHIOPRINE; ENZYME ANTIBODY; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; MYCOPHENOLIC ACID; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FEMALE; HUMAN; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME;

ADULT; ANTIBODIES; FEMALE; HUMANS; MIDDLE AGED; MYASTHENIA GRAVIS; PLASMAPHERESIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC;

EID: 35649022743     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.05.033     Document Type: Article

References (7)

1. Vincent A., and Leite M.I. Neuromuscular junction autoimmune disease: Muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 18 (2005) 519-525
2. Evoli A., Tonali P.A., Padua L., Monaco M.L., Scuderi F., Batocchi A.P., et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 (2003) 2304-2311
3. Yeh J.H., and Chiu H.C. Plasmapheresis in myasthenia gravis - comparative study of daily versus alternately daily schedule. Acta Neurol Scand 99 (1999) 147-151
4. Yeh J.H., and Chiu H.C. Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis. J Clin Apheresis 14 (1999) 177-180
5. Yeh J.H., and Chiu H.C. Comparison between double filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis. J Neurol 247 (2000) 510-513
6. Scuderi F., Marino M., Colonna L., Mannella F., Evoli A., Provenzano C., et al. Anti-p110 autoantibodies identify a subtype of 'seronegative' myasthenia gravis with prominent oculobulbar involvement. Lab Invest 82 (2002) 1139-1146
7. Thorlacius S., Lefvert A.K., Aarli J.A., Gilhus N.E., Halvorsen K., Hofstad H., et al. Plasma exchange in myasthenia gravis: Effect on anti-acetylcholine receptor antibodies and other autoantibodies. Acta Neurol Scand 74 (1986) 486-490